IBDEI264 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36368,0)
 ;;=J9310^^167^1840^83^^^^1
 ;;^UTILITY(U,$J,358.3,36368,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36368,1,1,0)
 ;;=1^J9310
 ;;^UTILITY(U,$J,358.3,36368,1,3,0)
 ;;=3^Rituxam Inj 100mg
 ;;^UTILITY(U,$J,358.3,36369,0)
 ;;=J9360^^167^1840^91^^^^1
 ;;^UTILITY(U,$J,358.3,36369,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36369,1,1,0)
 ;;=1^J9360
 ;;^UTILITY(U,$J,358.3,36369,1,3,0)
 ;;=3^Vinblastine Sulfate (Velban) Inj 1mg
 ;;^UTILITY(U,$J,358.3,36370,0)
 ;;=J9370^^167^1840^92^^^^1
 ;;^UTILITY(U,$J,358.3,36370,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36370,1,1,0)
 ;;=1^J9370
 ;;^UTILITY(U,$J,358.3,36370,1,3,0)
 ;;=3^Vincristine Sulfate (VCR) Inj 1mg
 ;;^UTILITY(U,$J,358.3,36371,0)
 ;;=J9390^^167^1840^69^^^^1
 ;;^UTILITY(U,$J,358.3,36371,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36371,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,36371,1,3,0)
 ;;=3^Navelbine Inj 10mg
 ;;^UTILITY(U,$J,358.3,36372,0)
 ;;=J9171^^167^1840^33^^^^1
 ;;^UTILITY(U,$J,358.3,36372,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36372,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,36372,1,3,0)
 ;;=3^Docetaxel Inj 1mg
 ;;^UTILITY(U,$J,358.3,36373,0)
 ;;=J9070^^167^1840^21^^^^1
 ;;^UTILITY(U,$J,358.3,36373,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36373,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,36373,1,3,0)
 ;;=3^Cyclophosphamide Inj 100mg
 ;;^UTILITY(U,$J,358.3,36374,0)
 ;;=J9351^^167^1840^88^^^^1
 ;;^UTILITY(U,$J,358.3,36374,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36374,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,36374,1,3,0)
 ;;=3^Topotecan Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,36375,0)
 ;;=J9035^^167^1840^12^^^^1
 ;;^UTILITY(U,$J,358.3,36375,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36375,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,36375,1,3,0)
 ;;=3^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,36376,0)
 ;;=J9041^^167^1840^14^^^^1
 ;;^UTILITY(U,$J,358.3,36376,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36376,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,36376,1,3,0)
 ;;=3^Bortezomib Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,36377,0)
 ;;=J9055^^167^1840^18^^^^1
 ;;^UTILITY(U,$J,358.3,36377,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36377,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,36377,1,3,0)
 ;;=3^Cetuximab Inj 10mg
 ;;^UTILITY(U,$J,358.3,36378,0)
 ;;=J8530^^167^1840^22^^^^1
 ;;^UTILITY(U,$J,358.3,36378,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36378,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,36378,1,3,0)
 ;;=3^Cyclophosphamide Oral 25mg
 ;;^UTILITY(U,$J,358.3,36379,0)
 ;;=J9206^^167^1840^54^^^^1
 ;;^UTILITY(U,$J,358.3,36379,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36379,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,36379,1,3,0)
 ;;=3^Irinotecan Inj 20mg
 ;;^UTILITY(U,$J,358.3,36380,0)
 ;;=J0135^^167^1840^2^^^^1
 ;;^UTILITY(U,$J,358.3,36380,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36380,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,36380,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,36381,0)
 ;;=Q2050^^167^1840^37^^^^1
 ;;^UTILITY(U,$J,358.3,36381,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36381,1,1,0)
 ;;=1^Q2050
 ;;^UTILITY(U,$J,358.3,36381,1,3,0)
 ;;=3^Doxorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,36382,0)
 ;;=J0129^^167^1840^1^^^^1
 ;;^UTILITY(U,$J,358.3,36382,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36382,1,1,0)
 ;;=1^J0129
 ;;^UTILITY(U,$J,358.3,36382,1,3,0)
 ;;=3^Abatacept Inj 10mg
 ;;^UTILITY(U,$J,358.3,36383,0)
 ;;=J0256^^167^1840^4^^^^1
 ;;^UTILITY(U,$J,358.3,36383,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36383,1,1,0)
 ;;=1^J0256
 ;;^UTILITY(U,$J,358.3,36383,1,3,0)
 ;;=3^Alpha 1 Proteinase Inh Inj 10mg
